• Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
  • Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      India's Aurobindo Gets USFDA Nod For Hypertension Drug

      Posted AtTradingmarkets.com

      Pharmaceutical firm Aurobindo Pharma (BSE:524804) said Thursday it has received tentative approval from US Food and Drug Administration to manufacture and market hypertension drug Losartan Potassium.

      The company has received the tentative approval to manufacture and market Losartan Potassium tablets in the strength of 25 mg, 50 mg and 100 mg from USFDA, Aurobindo Phrama said in a filing to the Bombay Stock Exchange.

      Losartan Potassium tablets are generic equivalent of Merck Research Laboratories Cozaar tablets of the equal strengths, the company said adding that it is the 75th Abbreviated New Drug Application (ANDA) approval from the US regulator.

      The branded sales of Losartan range of products was US$1,235 million, for the year ended December 2007, according to Merck Financial disclosures.

      Shares of the company were trading at Rs 306, down 1.18 per cent on BSE in afternoon trade.

      August 26, 2008


       

      Share this Article!

    Back to top^